Repare Therapeutics Inc. (RPTX) Social Stream
Repare Therapeutics Inc (RPTX) Price Targets From Analysts
Use the tables below to see what analysts covering Repare Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
RPTX's average price target has moved up $0.95 over the prior 103 days.
Over the past 13 months, RPTX's average upside potential has been 40.96%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RPTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 31 days, RPTX's average broker recommendation rating improved by 0.78.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- RPTX has a greater upside potential (average analyst target price relative to current price) than 356.86% of all US stocks.
- In terms of how Repare Therapeutics Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 378.95% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Repare Therapeutics Inc's average analyst price target is higher than 340.36% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Repare Therapeutics Inc's variance in analysts' estimates is lower than -11.93% of them.
Is RPTX a Buy, Hold or Sell? See the POWR Ratings now!